(Q40594940)

21 September 2017

1 reference

title

Cytoprotection: concepts and challenges (English)

1 reference

21 September 2017

1

1 reference

21 September 2017

publication date

1 November 1994

1 reference

Supportive Care in Cancer

21 September 2017

published in

1 reference

21 September 2017

volume

2

1 reference

21 September 2017

issue

6

1 reference

21 September 2017

page(s)

377-379

1 reference

5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis

21 September 2017

cites work

1 reference

12 December 2020

Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity

1 reference

12 December 2020

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

1 reference

12 December 2020

Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer

1 reference

12 December 2020

Hexamethylmelamine and Low or Moderate Dose Cisplatin With or Without Pyridoxine for Treatment of Advanced Ovarian Carcinoma: A Study of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats

1 reference

12 December 2020

Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma

1 reference

12 December 2020

Biological Factors Affecting the Radioprotective Efficiency of S-2-[3-Aminopropylamino] Ethylphosphorothioic Acid (WR-2721). LD 50(30) Doses

1 reference

12 December 2020

Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival

1 reference

12 December 2020

Improvement in the therapeutic index of cisplatin (NSC 119875) by pharmacologically induced chloruresis in the rat

1 reference

12 December 2020

Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport

1 reference

12 December 2020

Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute

1 reference

12 December 2020

Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDP.

1 reference

12 December 2020

Factors influencing the specificity of action of an antileukemic agent (aminopterin); multiple treatment schedules plus delayed administration of citrovorum factor

1 reference

12 December 2020

Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721.

1 reference

12 December 2020

Efficacy and safety of high-dose cisplatin and cyclophosphamide with glutathione protection in the treatment of bulky advanced epithelial ovarian cancer

1 reference

12 December 2020

Amifostine-mediated protection of normal bone marrow from cytotoxic chemotherapy

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/fas6lxun65cyhmb4kfmbrmpi2i

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Dimensions Publication ID

1002516498

0 references

Fatcat ID

release_fas6lxun65cyhmb4kfmbrmpi2i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fas6lxun65cyhmb4kfmbrmpi2i

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/fas6lxun65cyhmb4kfmbrmpi2i

1 reference

30 July 2022